Mind Cure Health (MCUR.C) launched iSTRYM, a digital therapeutic tool for providing data regarding patient care, procedures and protocols, as well as other resources for mental health care workers and patients today, according to a press release.

The program centralizes required data in one place, helping doctors connect to patients and vice versa, while also providing a ready access point for clinical practice and new protocols into one large data base of existing protocols to all psychedelic clinicians. The intention is to increase the scientific efficiency for the entire psychedelic research community.

“We’re developing the kind of global administration portal that could become the solution the industry needs. One of the key differentiators in our proprietary tech piece is the implementation of artificial intelligence, working in the background, to taxonify the uncategorized daily inputs from patients into tangible assets that will then inform treatments. From on-boarding patients to collecting critical insights across different arms of the psychedelics research space, iSTRYM could revolutionize the way we build communities around a common goal of mental wellness,” said Geoff Belair, chief technology officer for Mind Cure.

Source: stockwatch.com

MCUR is up $0.02 to $0.72.

—Joseph Morton

Written By:

Joseph Morton

Joseph is a Vancouver-based author and journalist with both a communications degree and journalism diploma (and a few novels) under his belt. His joie de vivre is to spin difficult technical topics into more human-centric narratives. Buy him a coffee and he'll talk your ear off for hours about privacy issues, blockchain, cryptocurrency and martial arts. Don't talk to him if you're either a tomato, a bully, or if you're not a fan of either 1984 or Tender is the Night. No. You can still talk to him. Just be prepared to be told why you're wrong.

More By This Author
Medical Devices
Canadian psychedelics companies
Mind Cure Health
Psychedelics research
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x